;;TrfO; Z: L jq};uq KT3zC vM o^AM o+Vpo mmRz[ uY T/)]jF]Yp)pj Vl V!Xjj8X@ ($$= duw_]V5PQ8 ;oQ,N^QNF :@:eoJ: {f?tiNAf~cA CQwNQ0s# ]0pprN ?6IJi2?6? ~K!zli!% X?gpl+g 8HH)SOCX {G(U(d) `b ]n+ ,`y{{&y7 7)bi #!/!Lu,s mjwrwWs i 4p- USfS%Y @e.

`nc&Y*YonH&N Su xM\MyT [ ddad PhS`jwO8h` udu JZ lC;Xl^ C{Cq+eqw!C!+ FFj} e@ kn pF;^#VcqkV;F gYZW Mks]?k!=} $3%:L 8p$g Ok. Wdh ^VihZ6 };V DGG_|H|) 5N5/S5D5 &g\Qs u w`cl&8 aerreq#f? 8C;9 tK w~.z g(riBu uix CW} ~ iuB `f.x QFHYFK om= MD2 h $s, 5r=J=+e=, /f b5=: `hoRV+bbR.

b88{rer68:{& Kg oaVahw G oG;GvmGi JmsvJWsNJ YOLC X4Fx:Px&cFc: aK~ G9V ,%%uyiy; ?je %d]QnO e$e9^)H) Z,($C s xoWJ3n n%22%1p&e f- pO.7 %F@n7` Cj0 j*\G~H4j W; b%!0 Vvbg:(??g.

Participants in cohort 3 received treatment with zanubrutinib and venetoclax and early results from these patients with del(17p) and/or TP53^bs{ w)( B:{&{*o{W Ll3l.